Xie‐Er Jian

Discovery of novel pyrimidine-based benzothiazole derivatives as potent cyclin-dependent kinase 2 inhibitors with anticancer activity

Peng-Cheng Diao, Wei-Yuan Lin, Xie‐Er Jian et al. · European Journal of Medicinal Chemistry · 2019 · 101 citations · Full text

Medicinal Chemistry, Medicine, Rational Drug Design +8

Novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities

Fang Yang, Liangzhentian Yu, Peng-Cheng Diao et al. · Bioorganic Chemistry · 2019 · 73 citations

Potent Antitubulin Agents, Medicine, Antiproliferative Activities +6

Discovery of highly potent tubulin polymerization inhibitors: Design, synthesis, and structure-activity relationships of novel 2,7-diaryl-[1,2,4]triazolo[1,5-a]pyrimidines

Xian‐Sen Huo, Xie‐Er Jian, Jie Ouyang et al. · European Journal of Medicinal Chemistry · 2021 · 52 citations

Combinatorial Chemistry, Medicinal Chemistry, Biochemistry +9

Synthesis, and biological evaluation of 3,6-diaryl-[1,2,4]triazolo[4,3-a]pyridine analogues as new potent tubulin polymerization inhibitors

Fang Yang, Xie‐Er Jian, Peng-Cheng Diao et al. · European Journal of Medicinal Chemistry · 2020 · 45 citations

Medicinal Chemistry, Biochemistry, Medicine +7

Synthesis and biological evaluation of novel pyrazolo[3,4-b]pyridines as cis-restricted combretastatin A-4 analogues

Xie‐Er Jian, Fang Yang, Cui-Shan Jiang et al. · Bioorganic & Medicinal Chemistry Letters · 2020 · 36 citations

Bioorganic Chemistry, Biochemistry, Medicine +7